Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 29.72 | N/A |
PEG Ratio (TTM) | -1.24 | N/A |
P/S Ratio (TTM) | 2.62 | N/A |
P/B Ratio (TTM) | 2.31 | N/A |
P/FCF Ratio (TTM) | -16.57 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (15%) |
Company | Industry |
---|---|---|
ROA (TTM) | 4.12% | N/A |
ROE (TTM) | 8.04% | N/A |
Net Profit Margin (TTM) | 8.78% | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -31.55% | 1,691.85% | N/A |
Revenue | 20.29% | 87.14% | N/A |
Net Income | -30.47% | 1,694.17% | N/A |
Cash Flow | 23.08% | 326.95% | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.23 | N/A |
Quick Ratio (TTM) | 1.08 | N/A |
D/E Ratio (TTM) | 0.45 | N/A |
Interest Coverage (TTM) | 4.63 | N/A |
Piotroski F-Score | 6 | N/A |
Altman Z-Score | 2.29 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |